Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 23;13:12055–12066. doi: 10.2147/OTT.S282053

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Zhang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-338-3p is a target gene of CASC15. (A) Schematic representation of the CASC15 3′-UTR containing the binding site for miR-338-3p. (B) The dual-luciferase reporter assay. (C) GSE28423 revealed that miR-338-3p was poorly expressed in OS. (D) There was a negative correlation between the expression of CASC15 and miR-338-3p. (E) CASC15 knockdown significantly increased the expression of miR-338-3p in OS cells. (F) The expression of miR-338-3p was upregulated by miR-338-3p mimic and downregulated by miR-338-3p inhibitor. (G) miR-338-3p inhibitor could reverse sh-CASC15 mediated upregulation of miR-338-3p. **p < 0.01.